Transgenic mouse models for Alzheimer's disease: the role of GSK-3β in combined amyloid and tau-pathology
- 1 October 2006
- journal article
- Published by Elsevier in Revue Neurologique
- Vol. 162 (10) , 903-907
- https://doi.org/10.1016/s0035-3787(06)75098-6
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Improved Long-Term Potentiation and Memory in Young Tau-P301L Transgenic Mice before Onset of Hyperphosphorylation and TauopathyJournal of Neuroscience, 2006
- Therapeutic effects of PKC activators in Alzheimer's disease transgenic miceProceedings of the National Academy of Sciences, 2004
- Decreased Cyclin-Dependent Kinase 5 (cdk5) Activity Is Accompanied by Redistribution of cdk5 and Cytoskeletal Proteins and Increased Cytoskeletal Protein Phosphorylation in p35 Null MiceJournal of Neuroscience, 2003
- Capacitive Calcium Entry Is Directly Attenuated by Mutant Presenilin-1, Independent of the Expression of the Amyloid Precursor ProteinJournal of Biological Chemistry, 2003
- Secretases as targets for the treatment of Alzheimer's disease: the prospectsThe Lancet Neurology, 2002
- Unhampered Prion Neuroinvasion despite Impaired Fast Axonal Transport in Transgenic Mice Overexpressing Four-Repeat TauJournal of Neuroscience, 2002
- Neuronal Deficiency of Presenilin 1 Inhibits Amyloid Plaque Formation and Corrects Hippocampal Long-Term Potentiation But Not a Cognitive Defect of Amyloid Precursor Protein [V717I] Transgenic MiceJournal of Neuroscience, 2002
- Modeling Alzheimer's disease in transgenic mice: effect of age and of Presenilin1 on amyloid biochemistry and pathology in APP/London miceExperimental Gerontology, 2000
- Aging Increased Amyloid Peptide and Caused Amyloid Plaques in Brain of Old APP/V717I Transgenic Mice by a Different Mechanism than Mutant Presenilin1Journal of Neuroscience, 2000
- Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor proteinNature, 1998